Mr. Lam is responsible for the creation, implementation and management of the CMS’s development and growth strategy. Mr. Lam has clinician experience and deep understanding and knowledge of China‘s pharmaceutical industry, possessing unique insight and extensive experience in R&D, marketing, promotion, sales and other value-added services. He received his bachelor’s degree in clinical medicine from Zhanjiang Medical College in 1986, which was renamed Guangdong Medical University. Mr.Lam is a member of the Nomination Committee of the Company.
Ms. Chen joined CMS in 1995 and has remained with the Group since then. Ms. Chen is responsible for the Group’s finance, accounting, investor relations, administrative affairs management and administrative government affairs. She holds an EMBA degree and is a senior accountant with extensive experience in financial management, fund raising, auditing and investor relations, etc. As at the end of the year 2024, Ms. Chen was awarded eight times the “Best CFO” in Healthcare and Pharmaceuticals by the Institutional Investor Magazine. Ms. Chen is the chairman of the Environmental, Social and Governance Committee of the Company.
